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ABSTRACT 
Breast cancer is one of the most wide-spread diseases among women in America. If the cancer is local, it is 
easily controlled by surgical resection. However, if the cancer cells metastasize, patient survival is significantly 
reduced. 70% of breast cancers can be targeted through estrogen receptors (ER) on the membrane, with 
compounds such as tamoxifen. However, tamoxifen shows unreliable outcomes on different patients and it is 
believed that the ineffectiveness of tamoxifen is related to the epithetical-mesenchymal transition (EMT) of 
cancer cells. To address this problem, we are designing a system that stimulates metastasis activation with the 
aim of incorporating the results in target identification for drugs. To mimic the cellular microenvironment in both 
3D and 2D, scaffold and plate seeding of T47D cell line, an ER+ breast cancer cell line, and human mammary 
fibroblast (HMF) has been utilized. To understand the activation state of secondary metastasis and identify the 
presence of drug-targeted receptors, IHC staining has been used. Only co-cultured samples of T47D and HMF 
in 3D showed EMT. The morphology of both cells, when kept isolated from each other, did not change, but 
epithelial markers appeared at the cytoplasm instead of the membrane after 7-days of co-culture. Our results 
suggest that communication of breast cancer cells with fibroblasts in 3D initiates secondary metastasis. We 
hypothesize that the EMT leads to loss of estrogen receptors and reduce medicines efficacy. 
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